Clinical Practice Guidelines for Management of Bipolar Disorder

Indian Journal of Psychiatry

Volumn 59, Issue 5, 2017, Pages S51-S66

  Shah, Nilesh ^a   Grover, Sandeep ^b   Rao, G ^c  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c Asha Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; GABAPENTIN; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROATE SEMISODIUM;

ANOREXIA; ATAXIA; BIPOLAR DISORDER; BREAST FEEDING; CAREGIVER STRAIN INDEX; CATATONIA; CLINICAL TRIAL (TOPIC); COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; DEPRESSION; DISTRESS SYNDROME; DIZZINESS; ELECTROCONVULSIVE THERAPY; FATIGUE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; INTERPERSONAL AND SOCIAL RHYTHM THERAPY; LIFESTYLE MODIFICATION; LIVER DISEASE; LIVER FUNCTION TEST; LIVER TOXICITY; MANIA; MEDICAL PROCEDURES; MENTAL DISEASE ASSESSMENT; NAUSEA; PATIENT CARE; PRACTICE GUIDELINE; RAPID CYCLING AFFECTIVE DISORDER; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SEIZURE; SUICIDE ATTEMPT; THYROID DISEASE; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREMOR; TUBULAR DYSFUNCTION;

EID: 85009360522     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.196974     Document Type: Review

References (42)

1. Merikangas KR, Jin R, He JP et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251
2. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry 2011; 72: 156-167
3. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, & Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry 2013; 14(3), 154-219
4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar disorders; 2013;15(1), 1-44
5. National Institute for Health and Care Excellence. Bipolar disorder: The assessment and management of bipolar disorders in adults, children and young people in primary and secondary care. Draft for consultation, April 2014. http://www.nice.org.uk/
6. American Psychiatric Association. Guideline Watch: Practice guideline for the treatment of patients with bipolar disorder, 2ndedn. Washington DC: American Psychiatric Association; 2005
7. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346-388
8. Cipriani Andrea, et al. "Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis." The Lancet 378.9799 (2011): 1306-1315
9. Fountoulakis KN, Kontis D, Gonda X, Yatham LN. A systematic review of the evidence on the treatment of rapid cycling bipolar disorder. Bipolar disorders; 2013; 15(2), 115-137
10. Rao PG. An overview of Indian research in bipolar mood disorder. Indian Journal of Psychiatry. 2010;52(Suppl1):S173-S177
11. Avasthi A, Grover S, Aggarwal M. Research on mood stabilizers in India. Indian J Psychiatry 2010;52, Suppl S3:355-61
12. Grover S, Avasthi A, Sinha V, Lakdawala B, Bathla M, Sethi S, Mathur D M, Kathuria P, Shah S, Baalasubramanian D S, Agarwal V, Deka K. Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India. Indian J Psychiatry 2014;56:253-64
13. Grover S, Avasthi A. Mood stabilizers in pregnancy and lactation. Indian J Psychiatry 2015;57, Suppl S2:308-23
14. Tighe SK, Mahon PB, Potash JB. Predictors of Lithium Response in Bipolar Disorder. Therapeutic Advances in Chronic Disease. 2011; 2(3):209-226
15. Cipriani A, Hawton K, Stockton S, & Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013; 346:f3646
16. Malhi GS, Tanious M. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations. CNS Drugs 2011; 25(4): 289-98
17. Ng F, Hallam K, Lucas N, Berk M. The role of lamotrigine in the management of bipolar disorder. Neuropsychiatric disease and treatment, 2007; 3(4), 463
18. Bowden, C. L., Asnis, G. M., Ginsberg, L. D., Bentley, B., Leadbetter, R., & White, R. Safety and tolerability of lamotrigine for bipolar disorder. Drug safety, 2004; 27(3), 173-184
19. Tränkner A, Sander C, Schönknecht P. (2013). A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder. Neuropsychiatric disease and treatment, 2013; 9, 101
20. Tohen M, Zhang F, Taylor CC, Burns P, Zarate C, Sanger T, Tollefson, G. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. Journal of affective disorders, 2001; 65(1), 85-93
21. Gao K, Gajwani P, Elhaj O, Calabrese JR. Typical and atypical antipsychotics in bipolar depression. The Journal of clinical psychiatry, 2005; 66(11), 1376-1385
22. Gigante AD, Lafer B, Yatham LN. Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder. CNS drugs, 2012; 26(5), 403-420
23. De Berardis D, Marini S, Carano A, Padovan Lang A, Cavuto M, Piersanti M, Di Giannantonio M. Efficacy and safety of long acting injectable atypical antipsychotics: a review. Current clinical pharmacology, 2013; 8(3), 256-264
24. Chou YH, Chu PC, Wu SW, Lee JC, Lee YH, Sun IW, Yen YC. A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clinical Psychopharmacology and Neuroscience, 2015; 13(2), 121
25. Joffe RT, MacQueen GM, Marriott M, Robb J, Begin H, Young LT. Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. ActaPsychiatricaScandinavica, 2002;105(6), 427-430
26. Thase ME, Sachs GS.. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biological psychiatry, 2000; 48(6), 558-572
27. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. American Journal of Psychiatry 2014; 161: 1537-47
28. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M. Antidepressant-induced mania in bipolar patients: identification of risk factors. Journal of Clinical Psychiatry, 2001; 62(4), 249-255
29. TohenM, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C,Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of general psychiatry, 2003; 60(11), 1079-1088
30. McElroy SL. Prescribing antidepressants for bipolar depression: what does the evidence say.The Journal of clinical psychiatry, 2014; 75(9), e24-e24
31. Silverstone T. Moclobemide vs. imipramine in bipolar depression: a multicentre doubleblindclinical trial. ActapsychiatricaScandinavica, 2001; 104(2), 104-109
32. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A,Vieta E. New treatment guidelines for acute bipolar depression: a systematic review. Journal of affective disorders, 2011; 129(1), 14-26
33. Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology, 2013; 16(7), 1673-1685
34. Schöttle D, Huber CG, Bock T, Meyer TD. Psychotherapy for bipolar disorder: a review of the most recent studies. Current opinion in psychiatry, 2011; 24(6), 549-555
35. Scott JAN, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Hayhurst H. Cognitive-behavioural therapy for severe and recurrent bipolar disorders. The British Journal of Psychiatry, 2006; 188(4), 313-320
36. Miklowitz DJ. A review of evidence-based psychosocial interventions for bipolar disorder. Journal of Clinical Psychiatry, 2006; 67, 28
37. Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT 2000; 16:204-207
38. Devanand DP, Polanco P, Cruz R, Shah S, Paykina N, Singh K, and Majors L: The efficacy of ECT in mixed affective states. J ECT 2000; 16:32-37
39. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994; 151:169-176
40. Ismail Shihabuddeen TM, Gopinath PS. Group meetings of caretakers of patients with schizophrenia and bipolar mood disorders. Indian J Psychiatry 2005;47:153-6
41. Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Bipolar Disord. 2015;17:63-75
42. Muneer A. The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review. Cureus. 2016 Apr; 8(4): e562